NCT06900998 - Effects of Nimodipine on Alcohol Drinking | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Alcohol Use Disorder

Interventions

DRUG

Nimodipine

Nimodipine will be administered orally beginning on the evening prior to the study lab session. 90mg doses will be administered at 6:00pm, 12:00am, 6:00am, and 12:00pm.

Trial Locations (1)

06519

Yale University School of Medicine (Connecticut Mental Health Center), New Haven

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER